Drugs@FDA document
SEROQUEL XR Letter · NDA 022047 SUPPL-43
Drugs@FDA document · CHEPLAPHARM · Feb 6, 2020
Key facts
| Drug name | SEROQUEL XR |
|---|---|
| Document type | Letter |
| Application | NDA022047 |
| Submission | SUPPL-43 |
| Company | CHEPLAPHARM |
| Document date | Feb 6, 2020 |
At a glance
- Labeling-Package Insert Document categories
- 10–99 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: